AS-51: Benefits from Carotid Stenting before Open Heart Surgery: A Single-Center Experience with 76 Patients

2009 ◽  
Vol 103 (9) ◽  
pp. 24B-25B
Author(s):  
Qian Yang ◽  
Xiong Jing Jiang ◽  
Yue Jin Yang ◽  
Hai Ying Wu ◽  
Run Ling Gao
2008 ◽  
Vol 56 (S 1) ◽  
Author(s):  
A Pritisanac ◽  
H Gulbins ◽  
A Abugameh ◽  
U Rosendahl ◽  
S Bauer ◽  
...  

2013 ◽  
Vol 61 (S 01) ◽  
Author(s):  
M Ernst ◽  
A Reinecke ◽  
M vd Brelie ◽  
J Cremer ◽  
N Haake

1978 ◽  
Vol 39 (02) ◽  
pp. 474-487 ◽  
Author(s):  
E R Cole ◽  
F Bachmann ◽  
C A Curry ◽  
D Roby

SummaryA prospective study in 13 patients undergoing open-heart surgery with extracorporeal circulation revealed a marked decrease of the mean one-stage prothrombin time activity from 88% to 54% (p <0.005) but lesser decreases of factors I, II, V, VII and X. This apparent discrepancy was due to the appearance of an inhibitor of the extrinsic coagulation system, termed PEC (Protein after Extracorporeal Circulation). The mean plasma PEC level rose from 0.05 U/ml pre-surgery to 0.65 U/ml post-surgery (p <0.0005), and was accompanied by the appearance of additional proteins as evidenced by disc polyacrylamide gel electrophoresis of plasma fractions (p <0.0005). The observed increases of PEC, appearance of abnormal protein bands and concomitant increases of LDH and SGOT suggest that the release of an inhibitor of the coagulation system (similar or identical to PIVKA) may be due to hypoxic liver damage during extracorporeal circulation.


Sign in / Sign up

Export Citation Format

Share Document